Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Filing text identifies registrant as HealthSouth; metadata references Encompass Health, which was the name adopted later).
Reporting Period: Quarterly period ended June 30, 2006.
Business Overview: HealthSouth is a major provider of rehabilitative health care, ambulatory surgery, and diagnostic imaging services. The company operates through four primary divisions: Inpatient, Surgery Centers, Outpatient, and Diagnostic, plus a Corporate and Other segment.
Strategic Update: On August 14, 2006, the company announced it would explore strategic alternatives to reposition its focus on the post-acute care sector. This includes potential spin-offs or sales of its surgery centers, outpatient rehabilitation, and diagnostic divisions. The company also announced plans to relist on the NYSE under the ticker "HLS" following a one-for-five reverse stock split.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2006 |
Six Months Ended June 30, 2006 |
|---|---|---|
| Net Operating Revenues | $787.5 million | $1,577.3 million |
| Net Loss | $(42.4) million | $(477.6) million |
| Net Loss Available to Common Shareholders | $(51.7) million | $(486.8) million |
| Loss Per Share (Basic & Diluted) | $(0.13) | $(1.22) |
| Adjusted Consolidated EBITDA | $135.9 million | $272.3 million |
| Cash and Cash Equivalents | $53.9 million | $53.9 million (Ending Balance) |
| Total Long-Term Debt | $3,273.8 million | $3,273.8 million (Ending Balance) |
| Shareholders' Deficit | $(2,019.8) million | $(2,019.8) million (Ending Balance) |
Material Changes vs. Prior Period
- Revenue Decline: Net operating revenues decreased 3.8% for the quarter and 5.2% for the six-month period compared to 2005. This was driven by volume declines across all segments due to the 75% Rule compliance (Inpatient), facility closures, and competition.
- Recapitalization Impact: The six-month net loss was significantly impacted by a $361.1 million "Loss on early extinguishment of debt" resulting from a major recapitalization in March 2006. This transaction replaced approximately $3 billion of prior indebtedness with new long-term debt.
- Settlement Expenses: The six-month period in 2005 included a $215.0 million charge for securities litigation settlements. The 2006 period included $17.3 million in government and class action settlement expenses, including a $3.0 million payment to the U.S. Postal Inspection Services.
- Interest Rate Swap: The company recorded a gain of $18.6 million for the quarter and $14.8 million for the six months related to an interest rate swap entered into in March 2006 to convert variable rate debt to fixed rates.
- Stock-Based Compensation: Adoption of FASB Statement No. 123(R) on January 1, 2006, increased compensation expense by $3.1 million for the quarter and $5.8 million for the six months.
Guidance, Outlook, and Risks
- Strategic Repositioning: Management is exploring the sale or spin-off of non-core divisions (Surgery Centers, Outpatient, Diagnostic) to deleverage the company and focus on inpatient rehabilitation. This process is expected to take approximately 12 months.
- Operational Challenges: The company faces downward price pressure from payors, specifically Medicare (IRF-PPS changes and ASC pricing freezes). Single-payor exposure remains a risk, with Medicare comprising ~47% of revenues.
- Liquidity and Debt: While the recapitalization extended debt maturities and reduced near-term refinancing risk, the company remains highly leveraged. It must meet significant cash obligations for government settlements ($128.7 million remaining on Medicare settlement; $75 million remaining on SEC settlement) through 2007.
- Legal and Regulatory: The company faces continuing investigations and litigation, including class actions and qui tam lawsuits. A non-prosecution agreement with the DOJ was reached in May 2006, but the DOJ reserved the right to prosecute if terms are violated.
- Internal Controls: Management concluded that disclosure controls and procedures were ineffective as of June 30, 2006, due to material weaknesses that existed as of December 31, 2005. Remediation efforts are ongoing.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the new Credit Agreement's interest coverage (1.65:1) and leverage (7.25:1) ratios, as non-compliance could trigger immediate repayment.
- Settlement Obligations: Confirm the schedule and funding for the remaining $203.7 million in government settlement payments due in 2006 and 2007.
- Strategic Alternatives: Monitor progress on the potential divestiture of Surgery Centers, Outpatient, and Diagnostic divisions to assess the timeline for deleveraging.
- Internal Controls: Review updates on the remediation of material weaknesses in internal controls over financial reporting.
- Volume Trends: Track patient volumes in the Inpatient segment to ensure compliance with the 75% Rule and monitor the impact of Medicare reimbursement changes.